David Suster

1.5k total citations
83 papers, 881 citations indexed

About

David Suster is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Rheumatology. According to data from OpenAlex, David Suster has authored 83 papers receiving a total of 881 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Pulmonary and Respiratory Medicine, 23 papers in Oncology and 23 papers in Rheumatology. Recurrent topics in David Suster's work include Sarcoma Diagnosis and Treatment (24 papers), Bone Tumor Diagnosis and Treatments (13 papers) and Myasthenia Gravis and Thymoma (12 papers). David Suster is often cited by papers focused on Sarcoma Diagnosis and Treatment (24 papers), Bone Tumor Diagnosis and Treatments (13 papers) and Myasthenia Gravis and Thymoma (12 papers). David Suster collaborates with scholars based in United States, Czechia and France. David Suster's co-authors include Saul Suster, Mari Mino–Kenudson, Gerard J. Nuovo, Cynthia M. Magro, Alexander C. Mackinnon, Esmerina Tili, Jose A. Plaza, Delia Pérez‐Montiel, Hamdy Awad and Herbert Auer and has published in prestigious journals such as Journal of Clinical Oncology, Biochemical and Biophysical Research Communications and Ophthalmology.

In The Last Decade

David Suster

66 papers receiving 871 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Suster United States 16 282 216 215 178 171 83 881
Giovanna A. Giannico United States 18 271 1.0× 150 0.7× 213 1.0× 241 1.4× 51 0.3× 64 936
Michael R. Clay United States 14 273 1.0× 171 0.8× 226 1.1× 150 0.8× 62 0.4× 47 691
Aruna Nambirajan India 17 303 1.1× 319 1.5× 319 1.5× 48 0.3× 109 0.6× 78 867
Stefan Gattenloehner Germany 14 286 1.0× 243 1.1× 235 1.1× 78 0.4× 64 0.4× 31 937
Calliope Maris Belgium 17 141 0.5× 190 0.9× 264 1.2× 33 0.2× 167 1.0× 41 1.0k
Maxime Mallet France 12 126 0.4× 176 0.8× 466 2.2× 69 0.4× 121 0.7× 29 1.4k
Atif Ahmed United States 17 302 1.1× 188 0.9× 328 1.5× 97 0.5× 142 0.8× 95 983
Serpil Dızbay Sak Türkiye 15 245 0.9× 187 0.9× 118 0.5× 88 0.5× 44 0.3× 92 775
Yoo-Jin Kim Germany 18 121 0.4× 230 1.1× 326 1.5× 52 0.3× 178 1.0× 35 961
Roos J. Leguit Netherlands 19 124 0.4× 214 1.0× 163 0.8× 69 0.4× 135 0.8× 43 887

Countries citing papers authored by David Suster

Since Specialization
Citations

This map shows the geographic impact of David Suster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Suster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Suster more than expected).

Fields of papers citing papers by David Suster

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Suster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Suster. The network helps show where David Suster may publish in the future.

Co-authorship network of co-authors of David Suster

This figure shows the co-authorship network connecting the top 25 collaborators of David Suster. A scholar is included among the top collaborators of David Suster based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Suster. David Suster is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gross, John, David Suster, Douglas A. Mata, Markku Miettinen, & Gregory W. Charville. (2025). 49 Expanding the Clinicopathologic Spectrum of Sarcomas with EWSR1::SSX Fusions. Laboratory Investigation. 105(3). 102272–102272. 1 indexed citations
2.
Suster, David, John Gross, Steven D. Billings, et al.. (2025). Superficial plexiform schwannoma of the skin and subcutis: Clinicopathological study of 48 cases. Histopathology. 87(6). 894–903.
3.
4.
Kalyoussef, Evelyne, Dylan F. Roden, Soly Baredes, et al.. (2024). Maackia amurensis seed lectin (MASL) and soluble human podoplanin (shPDPN) sequence analysis and effects on human oral squamous cell carcinoma (OSCC) cell migration and viability. Biochemical and Biophysical Research Communications. 710. 149881–149881. 1 indexed citations
5.
Suster, David, Alexander C. Mackinnon, & Saul Suster. (2024). Insulinoma-Associated Protein-1 Expression in Lymphoepithelial Carcinoma of the Thymus: A Potential Pitfall for Diagnosis With Neuroendocrine Carcinomas of the Thymus. Archives of Pathology & Laboratory Medicine. 149(2). e31–e35. 1 indexed citations
6.
Suster, David, et al.. (2024). Non-small cell lung carcinoma with clear cell features: a clinicopathologic, immunohistochemical, and molecular study of 31 cases. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 485(1). 83–96. 1 indexed citations
7.
Suster, David, et al.. (2024). Insulinoma-associated protein-1 (INSM-1) is a useful diagnostic marker for the evaluation of primary thymic neuroendocrine neoplasms: an immunohistochemical study of 27 cases. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 486(4). 721–727. 1 indexed citations
8.
Thompson, Lester D.�R., Martin Hyrcza, Tomáš Vaněček, et al.. (2023). Branchioma: immunohistochemical and molecular genetic study of 23 cases highlighting frequent loss of retinoblastoma 1 immunoexpression. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 484(1). 103–117.
9.
Suster, David, et al.. (2023). Thymic Parenchymal Hyperplasia. Modern Pathology. 36(8). 100207–100207. 2 indexed citations
10.
Suster, David, et al.. (2022). Rosai-Dorfman Disease. Ophthalmology. 130(7). 725–725. 1 indexed citations
11.
Suster, David, et al.. (2022). Epithelioid osteoblastoma. Clinicopathologic and immunohistochemical study of 17 cases. Human Pathology. 125. 68–78. 3 indexed citations
12.
Mezache, Louisa, Gerard J. Nuovo, David Suster, et al.. (2022). Histologic, viral, and molecular correlates of heart disease in fatal COVID-19. Annals of Diagnostic Pathology. 60. 151983–151983. 12 indexed citations
13.
Felix, Juan C., Yuri Sheinin, David Suster, et al.. (2021). Diffuse interstitial pneumonia-like/macrophage activation syndrome-like changes in patients with COVID-19 correlate with length of illness. Annals of Diagnostic Pathology. 53. 151744–151744. 5 indexed citations
14.
Suster, David & Mari Mino–Kenudson. (2020). Molecular Pathology of Primary Non-small Cell Lung Cancer. Archives of Medical Research. 51(8). 784–798. 79 indexed citations
15.
Lans, Jonathan, René M. Castelein, David Suster, et al.. (2020). Benign Hand Tumors (Part I): Cartilaginous and Bone Tumors. Hand. 17(2). 346–353. 4 indexed citations
16.
Suster, David. (2020). The role of molecular pathology in mediastinal sarcomas. Mediastinum. 4. 33–33. 4 indexed citations
17.
Suster, David & Saul Suster. (2020). The role of needle core biopsies in the evaluation of thymic epithelial neoplasms. Journal of the American Society of Cytopathology. 9(5). 346–358. 5 indexed citations
18.
Nuovo, Gerard J., Cynthia M. Magro, Hamdy Awad, et al.. (2020). Endothelial cell damage is the central part of COVID-19 and a mouse model induced by injection of the S1 subunit of the spike protein. Annals of Diagnostic Pathology. 51. 151682–151682. 103 indexed citations
19.
Suster, David, et al.. (2018). Intra-articular fibroma-like perivascular epithelioid tumor (PEComa) mimicking tenosynovial giant cell tumor, diffuse type. Skeletal Radiology. 48(6). 965–969. 5 indexed citations
20.
Suster, David, Jose A. Plaza, & Rulong Shen. (2005). Low-grade malignant perineurioma (perineurial sarcoma) of soft tissue: a potential diagnostic pitfall on fine needle aspiration. Annals of Diagnostic Pathology. 9(4). 197–201. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Giovanna A. Giannico Breakdown of academic impact, for papers by Michael R. Clay Breakdown of academic impact, for papers by Aruna Nambirajan Breakdown of academic impact, for papers by Stefan Gattenloehner Breakdown of academic impact, for papers by Calliope Maris Breakdown of academic impact, for papers by Maxime Mallet Breakdown of academic impact, for papers by Atif Ahmed Breakdown of academic impact, for papers by Serpil Dızbay Sak Breakdown of academic impact, for papers by Yoo-Jin Kim Breakdown of academic impact, for papers by Roos J. Leguit
Rankless by CCL
2026